Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

Men with BRCA1 and BRCA2 gene mutations should be given annual prostate cancer screening checks, leading scientists have said ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.

EFFICIENT DIAGNOSES Siteman is exploring new avenues of treating cancer with theranostics, which combines diagnostic testing and therapy. Available through the center at Barnes-Jewish Hospital and ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical research results of its novel B7-H3-targeting ADC (R&D code: 7MW3711) for multiple ...

Lung cancer is rising beyond smokers, affecting women and youth due to pollution, indoor smoke, and occupational hazards. Experts urge early diagnosis, tobacco control, clean air, and equitable ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Two worlds collide in this twisty crime thriller set along the Irish border, as a pair of mismatched detectives must solve a ...